| Korlym (mifepristone) / Corcept Therap |
NCT00130676: A United States Study of Corlux for Psychotic Symptoms in Psychotic Major Depression |
|
|
| Completed | 3 | 257 | US | Mifepristone, matching placebo | Corcept Therapeutics | Major Depressive Disorder, Psychotic Disorders | 06/06 | 06/06 | | |
NCT00146523: An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression |
|
|
| Completed | 3 | 247 | Europe, RoW | Mifepristone, placebo | Corcept Therapeutics | Major Depressive Disorder | 07/06 | 07/06 | | |
NCT00208156: A United States Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression |
|
|
| Completed | 3 | 87 | US | Mifepristone | Corcept Therapeutics | Depressive Disorder, Major | 11/06 | 11/06 | | |
NCT00128505: An International Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression |
|
|
| Completed | 3 | 104 | Europe, RoW | Mifepristone | Corcept Therapeutics | Major Depressive Disorder, Psychotic Disorders | 11/06 | 11/06 | | |
NCT00128479: A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression |
|
|
| Completed | 3 | 443 | US | mifepristone, mifepristone matched placebo, mifepristone 600 mg, mifepristone 1200 mg | Corcept Therapeutics | Major Depressive Disorder, Psychotic Disorders | 01/07 | 01/07 | | |
NCT00637494: A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features |
|
|
| Terminated | 3 | 292 | US | mifepristone, Korlym, placebo, control | Corcept Therapeutics | Psychotic Depression, Severe Major Depression With Psychotic Features, Psychosis | 06/14 | 06/14 | | |
